Zura Bio grants 425,700 options to legal chief

Zura Bio Ltd reported that its Chief Legal Officer, Davis Kim, received an employee stock option grant covering 425,700 Class A Ordinary Shares.

Rhea-AI Filing Summary

Zura Bio Ltd reported that its Chief Legal Officer, Davis Kim, received an employee stock option grant covering 425,700 Class A Ordinary Shares. The options have an exercise price of $6.03 per share and expire on April 1, 2036.

According to the vesting terms, one fourth of the option award vests on April 1, 2027, with the remaining options vesting in equal quarterly installments thereafter, contingent on Kim’s continued service. This is a compensation-related award rather than an open-market share purchase or sale.

Insider Trade Summary

Grant/Award: 425,700 shares

Grant/Award 1 txn

Insider Davis Kim

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Share Option (Right to Buy)	425,700	$0.00	$0.00

Holdings After Transaction: Employee Share Option (Right to Buy) — 425,700 contracts (Direct)

Footnotes (1)

1. F1. One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Key Figures

Option grant size: 425,700 options Exercise price: $6.03 per share Underlying shares: 425,700 shares +3 more

6 metrics

Option grant size 425,700 options Employee Share Option grant to Chief Legal Officer

Exercise price $6.03 per share Exercise price for Employee Share Option award

Underlying shares 425,700 shares Class A Ordinary Shares underlying the option award

Post-grant derivative holdings 425,700 options Total derivative securities following the reported transaction

Vesting start date April 1, 2027 One fourth of options vest on this date

Expiration date April 1, 2036 Option award expiration if not exercised

Key Terms

Employee Share Option (Right to Buy), Class A Ordinary Shares, exercise price, vesting, +1 more

5 terms

Employee Share Option (Right to Buy) financial

"security_title: Employee Share Option (Right to Buy)"

Class A Ordinary Shares financial

"underlying_security_title: Class A Ordinary Shares"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

exercise price financial

"conversion_or_exercise_price: 6.0300"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"the shares subject to the option award shall vest on April 1, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

expiration date financial

"expiration_date: 2036-04-01T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Zura Bio (ZURA) disclose about Davis Kim in this Form 4?

Zura Bio disclosed that Chief Legal Officer Davis Kim received an employee stock option grant for 425,700 shares. The award is part of his compensation package and does not represent an open-market stock purchase or sale.

How many options did Zura Bio’s Chief Legal Officer receive and at what price?

Chief Legal Officer Davis Kim received options covering 425,700 Class A Ordinary Shares with an exercise price of $6.03 per share. This means he can buy shares at $6.03 once the options vest and are exercised.

When do Davis Kim’s Zura Bio stock options start vesting and when do they expire?

The options begin vesting on April 1, 2027, when one fourth of the award vests. The remaining options vest in equal quarterly installments thereafter, and the entire option grant expires on April 1, 2036 if not exercised.

Is the Zura Bio (ZURA) Form 4 transaction a stock purchase or sale by Davis Kim?

No, it is not a market purchase or sale. The Form 4 reports a grant of employee stock options to Chief Legal Officer Davis Kim as compensation, giving him the right to buy shares later at a fixed exercise price.

How many shares can be acquired under Davis Kim’s Zura Bio option award?

The option grant allows Chief Legal Officer Davis Kim to acquire up to 425,700 Class A Ordinary Shares of Zura Bio, subject to vesting conditions and his decision to exercise the options before their expiration date in 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 06:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Davis Kim

(Last) (First) (Middle)

C/O ZURA BIO LTD

1489 WEST WARM SPRINGS ROAD, #110

(Street)

HENDERSON NEVADA 89014

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Zura Bio Ltd [ ZURA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Share Option (Right to Buy)	$6.03	04/01/2026		A		425,700		(1)	04/01/2036	Class A Ordinary Shares	425,700	$0	425,700	D

Explanation of Responses:

1. One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

	/s/ Kim Davis	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)